Gabor Oroszlan

Company: VRG Therapeutics

Job title: Project Manager, Silico Lead

Bio:

As an In Silico Lead, I manage the development and operational oversight of VRG’s proprietary miniprotein platform, AI-MPRO. I oversee in silico processes and guide the transition of early-stage projects into the in vitro pipeline. I have deep expertise in molecular biochemistry, structural biology, and cross-functional project management.
I am passionate about collaborating with innovative, high-performing, and motivated teams on cross-functional pharmaceutical projects to tackle emerging scientific challenges, advancing the development of new therapies and drug discovery. I believe that real success is achieved only within stimulating communities driven by purpose, passion, vision, and clear goals.

Seminars:

Selective Targeting with Precision-Engineered Miniproteins and Beyond 9:00 am

Discuss strategies for designing miniproteins within strict size and stability constraints Address key challenges in combining de novo design with natural scaffold–based approaches Integrate structure- and sequence-driven approaches to unlock improved therapeutic properties NEW COMPANY!Read more

day: Conference Day Two

Panel Discussion: From Hype to Impact – Realizing the Value of AI in Biologics Design 4:10 pm

What are the current limitations and tangible successes in applying AI/ML to biologics discovery and developability? How are organizations measuring ROI from computational investments — speed, cost, accuracy, or all three? What infrastructure, culture, and talent are needed to effectively scale AI adoption across discovery and development pipelines?Read more

day: Conference Day One